Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 3/20 | 0.49 |
| ▸ | REN | P00797 | 3/20 | 0.49 |
| ▸ | XIAP | P98170 | 1/20 | 0.44 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.43 |
| ▸ | CTSD | P07339 | 1/20 | 0.43 |
| ▸ | BACE1 | P56817 | 1/20 | 0.43 |
| ▸ | NPY1R | P25929 | 1/20 | 0.42 |
| ▸ | NPY2R | P49146 | 1/20 | 0.42 |
| ▸ | NPY4R | P50391 | 1/20 | 0.42 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.42 |
| ▸ | NTSR1 | P30989 | 6/20 | 0.42 |
| ▸ | NTSR2 | O95665 | 5/20 | 0.42 |
| ▸ | SORT1 | Q99523 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29590352 | 0.94 | BACE1 (0.46) | ACERENCTSDBACE1NPY1R | |
| SCHEMBL31316151 | 0.90 | F2R (0.43) | ACERENXIAPENPEPCTSD | |
| SCHEMBL32672659 | 0.89 | XIAP (0.50) | ACERENXIAPNPY1RNPY2R | |
| SCHEMBL30435414 | 0.87 | ACE (0.51) | ACERENCTSDBACE1 | |
| SCHEMBL30435255 | 0.87 | ACE (0.51) | ACERENCTSDBACE1 | |
| SCHEMBL29823571 | 0.87 | XIAP (0.47) | ACERENXIAPENPEPNPY1R | |
| SCHEMBL29839435 | 0.86 | ACE (0.44) | ACERENXIAPENPEPCTSD | |
| SCHEMBL29873831 | 0.85 | XIAP (0.51) | XIAPENPEPCTSDBACE1NTSR1 | |
| SCHEMBL1323636 | 0.84 | ACE (0.56) | ACEREN | |
| SCHEMBL12120319 | 0.84 | ACE (0.56) | ACEREN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |